The US Food and Drug Administration issued a warning this week to
those who use over-the-counter laxatives to help ease constipation.
These products “are potentially dangerous if dosing instructions or
warnings on the Drug Facts label are not properly followed or when there
are certain coexisting health conditions,” stated the FDA on their website.
The agency has received dozens of reports of serious side effects,
including 13 deaths, associated with the use of sodium phosphate
laxatives like Fleet or generic versions of the phospho-soda or enema
product.
Consumers should follow instructions and only use these laxatives—swallowed as a liquid or used as an enema—as a single dose, once a day. The products shouldn’t be used for more than three consecutive days.
“Equally important, consumers who do not have a bowel movement after taking an oral or rectal dose should not take another dose of the product,” the FDA stated. It can cause dehydration by drawing water into the bowel.
The FDA recommended that adults over age 55 and anyone with kidney disease, heart problems, or signs of dehydration should check with their doctor before using a Fleet product because they could be an increased risk of dangerous side effects.
Consumers should follow instructions and only use these laxatives—swallowed as a liquid or used as an enema—as a single dose, once a day. The products shouldn’t be used for more than three consecutive days.
“Equally important, consumers who do not have a bowel movement after taking an oral or rectal dose should not take another dose of the product,” the FDA stated. It can cause dehydration by drawing water into the bowel.
The FDA recommended that adults over age 55 and anyone with kidney disease, heart problems, or signs of dehydration should check with their doctor before using a Fleet product because they could be an increased risk of dangerous side effects.
Laxatives associated with fewer health risks include
psyllium, a soluble fiber, mineral oil, or methylcellulose (another
plant fiber) and glycerin suppositories.
Deborah Kotz can be reached at dkotz@globe.com. Follow her on Twitter @debkotz2.
Comments